Persephone
3 known investors
Persephone produces a synbiotic supplement combining probiotics and prebiotics for infants to address deficiencies in the infant gut microbiome and support digestive health, immunity, and development. The product is developed by microbiome scientists and pediatricians and is clinically validated for safety and effectiveness.
BiotechHealthtech
Founders & leadership
SC
Stephanie CullerCEO & Co-Founder
Investors · 3
In the news
- Inside Persephone’s Strategy: Unlocking the Microbiome for Scalable Precision Therapeutics -biotechmetro.com · 2025
- Persephone Biosciences Secures $15M Seed Round to Transform Engineered Cell Therapeutics for Healthier Human Ecosystems | SignalBasetrysignalbase.com · 2025
- "Seeking Persephone" novel is in the process of becoming a filmfox13now.com · 2023
- Persephone rakes in $15M to support country’s biggest cancer microbiome study - MedCity Newsmedcitynews.com · 2022
- Persephone Biosciences Closes $15M Seed Financing - FinSMEsfinsmes.com · 2022
- Persephone Biosciences - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021